Read More
Hutchison China MediTech has opened its retail book today to raise up to HK$4.68 billion.
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT
The biopharma company is targeting the global market for novel, highly selective oral oncology and immunology drugs.
The minimum investment is HK$22,727 of 500 shares.
The offer price upper range is HK$45.
The company will set the price next Wednesday and debut on June 30.
Five cornerstone investors have signed up to invest a total of HK$2.54 billion.
